Highlights and Quick Summary
- Investments Change (Net) for the quarter ending September 30, 2023 was $-34.9 Million (a -216.18% decrease compared to previous quarter)
- Year-over-year quarterly Investments Change (Net) increased by 292.93%
- Annual Investments Change (Net) for 2022 was $-30.3 Million (a -56.02% decrease from previous year)
- Twelve month Investments Change (Net) ending September 30, 2023 was $-24.4 Million (a -1494.63% decrease compared to previous quarter)
- Twelve month trailing Investments Change (Net) decreased by -19.59% year-over-year
Trailing Investments Change (Net) for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| $-24.4 Million | $1.75 Million | $-73.5 Million | $-30.3 Million |
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Investments Change (Net) of Prime Medicine, Inc.
Most recent Investments Change (Net)of PRME including historical data for past 10 years.Interactive Chart of Investments Change (Net) of Prime Medicine, Inc.
Prime Medicine, Inc. Investments Change (Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-34.86 | $30.01 | $-10.67 | – | – |
| 2022 | $-8.87 | $-8.72 | $-45.24 | $32.5 | $-30.34 |
| 2021 | – | – | $12.86 | $-81.84 | $-68.98 |
| 2020 | $0.0 | – | – | – | – |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology